About US
Contact us
-
SFDA Commissioner Yin Li meets Cuban Ambassador to ChinaOn the afternoon of June 13, 2012, Yin Li, Commissioner of the State Food and Drug Administration (SFDA), met with the visiting Mr. Alberto Jesús Blanco Silva, the Cuban Ambassador Extraordinary and P2012/6/25
-
Novartis' Afinitor gets nod for breast cancer use by EU committeeNovartis ($NVS) got what it had hoped for Friday, a thumbs up from the EU's Committee for Medicinal Products for Human Use (CHMP) for a new use for its cancer drug Afinitor. The CHMP recommended it fo2012/6/22
-
FDA delivers Xarelto bad news to J&J, BayerThe expected news on Xarelto has been delivered to Johnson & Johnson ($JNJ) and Bayer. In its complete response letter, the FDA turned down their request that it be approved to prevent heart attac2012/6/22
-
Anti-overtime ruling a disguised blessing for reps, recruiters sayThe Supreme Court denied pharma sales reps their overtime. But it may have saved many of their jobs--not to mention their bonuses, industry recruiters say. If the ruling had gone in the reps' favor, d2012/6/21
-
J&J close to $1.5B-plus Risperdal settlement, but not there yetThe latest on Johnson & Johnson's ($JNJ)Risperdal settlement: It may not be as close--or as big--as we previously thought. Then again, it could be bigger. TheThe Wall Street Journal reports that J2012/6/21
-
Roche slashes MabThera price in S. Africa to drive salesDrugmakers are chafing under European price cuts. But more and more, they're cutting prices on their own in the developing world. It's part of the strategy to increase emerging markets sales, a recogn2012/6/20
-
CSL confirms Fluvax manufacturing tied to convulsions in childrenIf it were not so serious, the FDA could be telling Australian vaccinemaker CSL"I told you so," after a two-year study apparently confirmed what the agency suggested in a warning letter in 2011: CSL's2012/6/20
-
Pfizer expects to wrap up Prempro suits for $1.2B totalThe price tag Pfizer's ($PFE) Prempro settlements is now in. The drugmaker has paid $896 million to wrap up about 60% of the patient lawsuits, Bloomberg reports. That's about 6,000 cases, all alleging2012/6/19
-
No overtime for pharma reps, Supreme Court saysThe Supreme Court has spoken to pharma reps. In a split decision, the justices ruled that drugmakers don't have to pay overtime to salespeople. It's a landmark ruling that will send a lot of lawsuits2012/6/19
-
Merck loses a patent ruling on blockbuster NasonexEven as the clock is ticking down on the patent for its super blockbuster Singulair, Merck ($MRK) got smacked Friday with a negative decision in its battle with genericmaker Apotex overMerck's blockbu2012/6/18